Instructions for Baneocin (Bacitracin)
Baneocin is an antimicrobial drug for external use. Combined drug Baneocin contains two bactericidal (destroying bacteria) with a synergistic effect (reinforcing each other's action when used together). The spectrum of antimicrobial action of neomycin includes most gram-positive and gram-negative microorganisms. Bacitracin is active mainly against gram-positive microorganisms (hemolytic streptococcus, staphylococcus, clostridia, Corynebacterium diphtheriae, Treponemapallidum); some gram-negative microorganisms (Neisseria, Haemophilusinfluenzae), as well as actinomycytes and fusobacteria.
Bacitracin resistance is extremely rare. Banercin is inactive against Pseudomonas, Nocardia, viruses and most fungi. Local application of the drug significantly reduces the risk of systemic sensitization (increased sensitivity of the body to the drug). Baneocin tissue tolerance is considered excellent; inactivation (loss of activity) of the drug by biological products, blood and tissue components is not observed.Baneocin powder promotes natural perspiration and has a pleasant cooling effect.
Baneocin Indications for use:
In dermatology (treatment of skin diseases), the preparation in powder form is used for the treatment and prevention of bacterial infections of the skin and superficial wounds, burns.
With secondary bacterial infection with Herpessimplex, Herpeszoster, chickenpox.
The ointment is used to treat bacterial infections of the skin and mucous membranes: contagious (transmitted from a patient to a healthy person / infectious /) impetigo (superficial pustular skin lesions with the formation of purulent crusts), boils (purulent inflammation of the hair follicle of the skin, spreading to surrounding tissues), carbuncles (acute diffuse purulent-necrotic inflammation of several sebaceous glands and hair follicles located nearby) - after their surgical treatment, folliculitis (inflammation of the hair follicles) of the scalp, purulent hydradenitis (purulent inflammation of the sweat glands), multiple abscess (abscesses) of the sweat glands, abscesses after opening, paronychia (inflammation of the periungual tissue), ecthyma (an inflammatory skin disease characterized by the appearance of pustules with deep ulceration in the center), pyoderma (purulent inflammation of the skin );
secondary infections with dermatoses (skin diseases - ulcers, eczema). For the treatment and prevention of secondary infections of wound surfaces, as well as for cosmetic procedures (piercing of the earlobe, transplantation / grafting / skin). In obstetrics and gynecology, it is used for treatment in the postoperative period for perineal ruptures and episiotomy (dissection of the perineum during childbirth to prevent its rupture), laparotomy (opening the abdominal cavity); for the treatment of mastitis (inflammation of the lactic ducts of the mammary gland) during drainage, for the prevention of mastitis. In otorhinolaryngology (treatment of diseases of the ear, throat and nose), the drug in the form of an ointment is used in the case of secondary infections in acute and chronic rhinitis (inflammation of the nasal mucosa), otitis externa (inflammation of the outer ear); for treatment in the postoperative period with interventions on the paranasal sinuses, mastoid process. In pediatric (children's) practice, the powder of the drug is used for the prevention of umbilical infections, as well as for bacterial diaper dermatitis (inflammation of the skin in infants with insufficiently frequent diaper change).
The ointment is used for the same indications as in adults.
Baneocin Mode of application:
Before prescribing a drug to a patient, it is desirable to determine the sensitivity of the microflora to it that caused the disease in this patient. The required amount of ointment or powder is applied to the affected area; if appropriate - under the bandage (the bandage helps to increase the effectiveness of the ointment). In adults and children, the powder is used 2-4 times a day; ointment - 2-3 times a day. The daily dose of the drug should not exceed 1 g. The course of treatment is 7 days. With a repeated course, the maximum dose should be halved. In patients with burns occupying more than 20% of the body surface, the powder should be applied once a day.
In the case of using baneocin for the prevention of mastitis, it is necessary to remove the remnants of the drug from the mammary gland with boiled water and sterile cotton wool before feeding.
Patients with impaired liver and kidney function should undergo blood and urine tests, as well as an audiometric study (determination of hearing acuity) before and during intensive therapy with baneocin. The drug should not be applied to the eyes. When using baneocin for the treatment of chronic dermatoses or chronic otitis media, the drug promotes sensitization to other drugs, including neomycin.
If there is systemic absorption (absorption into the blood) of baneocin, the simultaneous administration of cephalosporin increases the risk of nephrotoxic (damaging the kidneys) side effects; the simultaneous appointment of furosemide, ethacrynic acid and aminoglycoside increases the risk of nephro- and ototoxic (damaging effects on the kidneys and hearing organs) side effects; and the appointment of muscle relaxants and local anesthetics - disorders of neuromuscular conduction.
Side effects Baneocin:
In rare cases, there is redness, dry skin, skin rashes and itching at the site of application of the drug.